Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patent Bill Damages Provision Still Up For Debate – Senate Committee Report

This article was originally published in The Gray Sheet

Executive Summary

A Senate Judiciary Committee 1report on a pending patent reform bill suggests a controversial provision on calculating infringement damages is still ripe for revision, but bill authors will not stray too far from their original intent

You may also be interested in...



Senators Willing To Negotiate On Patent Reform Bill Damage Provisions

Lawmakers say they are willing to negotiate controversial provisions on infringement damage awards included in the latest versions of House and Senate patent reform bills

Senators Willing To Negotiate On Patent Reform Bill Damage Provisions

Senate bill introduced March 3 includes some flexibility for the court to hear expert testimony to aid damage determinations and to consider unspecified “additional factors,” if appropriate.

Senators Willing To Negotiate On Patent Reform Bill Damage Provisions

Lawmakers say they are willing to negotiate controversial provisions on infringement damage awards included in the latest versions of House and Senate patent reform bills

Related Content

UsernamePublicRestriction

Register

OM017181

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel